Molindone, a new type of antipsychotic drug. 1968

J Shelton, and J J Prusmach, and L E Hollister

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties

Related Publications

J Shelton, and J J Prusmach, and L E Hollister
July 1975, The Medical letter on drugs and therapeutics,
J Shelton, and J J Prusmach, and L E Hollister
January 1970, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,
J Shelton, and J J Prusmach, and L E Hollister
January 1967, Clinical pharmacology and therapeutics,
J Shelton, and J J Prusmach, and L E Hollister
August 1990, Archives of psychiatric nursing,
J Shelton, and J J Prusmach, and L E Hollister
May 2003, The Annals of pharmacotherapy,
J Shelton, and J J Prusmach, and L E Hollister
September 2004, Fortschritte der Neurologie-Psychiatrie,
J Shelton, and J J Prusmach, and L E Hollister
February 1996, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
J Shelton, and J J Prusmach, and L E Hollister
June 2001, Pharmacotherapy,
J Shelton, and J J Prusmach, and L E Hollister
May 1996, The British journal of psychiatry. Supplement,
J Shelton, and J J Prusmach, and L E Hollister
January 2008, Therapie,
Copied contents to your clipboard!